Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJH0C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,099
Award facts
- Contract value 100% obligated
- $10,098.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,098.65 to AmerisourceBergen Drug Corp for the supply of Wegovy 2.4 mg/0.75 mL pens on January 9, 2026, with a completion date of January 12, 2026. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract is issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2031, serving as the overarching vehicle for this and similar pharmaceutical supply orders.
AmerisourceBergen operates as a critical pharmaceutical distributor supporting federal military and healthcare systems, leveraging its comprehensive IDC to deliver a broad range of medications and medical commodities globally. This particular delivery order for Wegovy, a diabetes and weight management medication, exemplifies the company's role in supplying specialized pharmaceutical products to Defense Health Agency and military treatment facilities. The non-set-aside competitive award reflects AmerisourceBergen's demonstrated capability to meet federal procurement standards and fulfill essential medical supply requirements across multiple therapeutic domains through the DLA's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26FJH0C?
SPE2DR26FJH0C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FJH0C worth?
The government has obligated $10,099 on SPE2DR26FJH0C.
Is contract SPE2DR26FJH0C an order under another contract?
Yes. SPE2DR26FJH0C is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJH0C competed?
The extent of competition for SPE2DR26FJH0C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award